Detection of viable Bifidobacterium lactis HN019 (DR10™) in stools of children during a synbiotic dietary intervention trial

International Dairy Journal

Volumn 30, Issue 2, 2013, Pages 64-67

  Prasad, Jaya ^a,d   Sazawal, Sunil ^b,c   Dhingra, Usha ^b   Gopal, Pramod K ^a  

^a FONTERRA RESEARCH CENTRE   (New Zealand)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c ANNAMALAI UNIVERSITY   (India)

^d Dairy Innovation Australia   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BIFIDOBACTERIA; BIFIDOBACTERIUM LACTIS; CLINICAL OUTCOME; EARLY CHILDHOODS; FAECAL SAMPLES; GALACTO-OLIGOSACCHARIDES; GASTROINTESTINAL TRACT; IN-CONTROL; PREBIOTICS; PROBIOTIC STRAIN; PROBIOTICS; TOTAL BACTERIA; TREATMENT GROUP; YOUNG CHILDREN;

BACILLI;

POLYMERASE CHAIN REACTION;

EID: 84873907292     PISSN: 09586946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idairyj.2012.12.001     Document Type: Article

References (17)

1. Ahmed M., Prasad J., Gill H., Stevenson L., Gopal P. Impact of consumption of different levels of Bifidobacterium lactis HN019 on intestinal microflora of elderly human subjects. Journal of Nutrition, Health and Aging 2007, 11:26-31.
2. Bakker-Zierikzee A., Alles M., Knol J., Kok F., Tolboom J., Bindels J. Effect of infant formula containing a mixture of galacto-oligosaccharides or viable Bifidobacterium animalis on intestinal microflora during the first four months of life. British Journal of Nutrition 2005, 94:783-790.
3. Balamurugan R., Magne F., Balakrishan D., Suau A., Ramani S., Kang G., et al. Faecal bifidobacteria in Indian neonates and the asymptomatic rotavirus infection during the first month of life. Indian Journal of Medical Research 2010, 132:721-727.
4. Bartosch S., Fite A., Macfarlane G.T., McMurdo M. Characterisation of bacterial communities in feces from healthy elderly volunteers and hospitalised elderly patients by using real-time PCR and effect of antibiotic treatment on the fecal microbiota. Applied and Environmental Microbiology 2004, 70:3575-3581.
5. Boehm G., Lidestri M., Casetta P., Jelinek J., Negretti F., Stahl B., et al. Supplementation of a bovine milk formula with oligosaccharide mixture increases counts of faecal bifidobacteria in pre term infants. Archives of Diseases in Children 2002, 86:F178-F181.
6. Bouhnik Y., Raskine L., Champion K., Andrieux C., Penven S., Jacobs H., et al. Prolonged administration of low-dose inulin stimulates the growth of bifidobacteria in humans. Nutrition Research 2007, 27:187-193.
7. Gopal P.K., Prasad J., Gill H.S. Effect of the consumption of Bifidobacterium lactis DR10 and galactooligosaccharides on the microecology of the gastrointestinal tract in human subjects. Nutrition Research 2003, 23:1313-1328.
8. Gopal P.K., Smart J.B., Sullivan P.A. Utilisation of galacto-oligosaccharides as selective substrates for growth by lactic acid bacteria including Bifidobacterium lactis DR10 and Lactobacillus rhamnosus DR20. International Dairy Journal 2001, 11:19-25.
9. Haarman M., Knol J. Quantitative real-time PCR assays to identify and quantify fecal Bifidobacterium species in infants receiving a prebiotic infant formula. Applied and Environmental Microbiology 2005, 71:2318-2324.
10. Malinen E., Kassinen A., Rinttila T., Palva A. Comparison of real-time PCR with SYBR Green I or 5'-nuclease assays and dot-blot hybridisation with rDNA-targeted oligonucleotide probes in quantification of selected faecal bacteria. Microbiology 2003, 149:269-277.
11. Moro G., Minoli I., Mosca M., Fanaro S., Jelinek J., Stahl B., et al. Dosage related bifidogenic effects of galacto- and fructooligo-saccharides in formula fed term infants. Journal of Pediatric Gasteroenterology and Nutrition 2002, 34:291-295.
12. Roger L.C., Castabile E., Holland D.T., Hoyles L., MacCartney A.T. Examination of faecal Bifidobacterium populations in breast- and formula-fed infants during the first 18 months of life. Microbiology 2010, 156:3329-3341.
13. Sanders M.E. Summary of probiotic activities of Bifidobacterium lactis HN019. Journal of Clinical Gastroenterology 2006, 40:776-783.
14. Sazawal S., Dhingra U., Hiremath G., Sarkar A., Dhingra P., Dutta A., et al. Prebiotic and probiotic fortified milk in prevention of morbidities among children: community-based, randomized, double-blind, controlled trial. PloS One 2010, 5:e12164. 1-8.
15. Sazawal S., Dhingra U., Hiremath G., Sarkar A., Dhingra P., Dutta A., et al. Effects of Bifodobacterium lactis HN019 and prebiotic oligosaccharide added to milk on iron status, anemia, and growth among children aged 1 to 4 years old. Journal of Pediatric Gastroenterology and Nutrition 2010, 51:341-346.
16. Tannock G.W., Munro K., Bibiloni R., Simon M.A., Hargreaves P., Gopal P., et al. Impact of consumption of oligosaccharides-containing biscuits on faecal microbiota of humans. Applied and Environmental Microbiology 2004, 70:2129-2136.
17. Tannock G.W., Munro K., Harmsen H.J.M., Welling G.W., Smart J., Gopal P.K. Analysis of the fecal microflora of human subjects consuming a probiotic containing Lactobacillus rhamnosus DR20. Applied and Environmental Microbiology 2000, 66:2578-2588.